Docusign (NASDAQ:DOCU) Director Anna Marrs Sells 548 Shares of Stock

Docusign Inc. (NASDAQ:DOCUGet Free Report) Director Anna Marrs sold 548 shares of Docusign stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $67.00, for a total transaction of $36,716.00. Following the completion of the transaction, the director owned 13,525 shares of the company’s stock, valued at $906,175. This represents a 3.89% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Performance

NASDAQ:DOCU opened at $71.85 on Wednesday. The stock has a 50-day simple moving average of $58.70 and a 200-day simple moving average of $51.06. The stock has a market cap of $13.43 billion, a P/E ratio of 43.81, a P/E/G ratio of 2.63 and a beta of 0.90. Docusign Inc. has a 1 year low of $40.16 and a 1 year high of $86.65.

Docusign (NASDAQ:DOCUGet Free Report) last announced its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. The firm had revenue of $875.75 million during the quarter, compared to the consensus estimate of $867.22 million. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The firm’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.30 earnings per share. On average, equities research analysts predict that Docusign Inc. will post 2.1 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Needham & Company LLC restated a “hold” rating on shares of Docusign in a research note on Friday, September 4th. Morgan Stanley boosted their price objective on Docusign from $69.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, September 4th. Bank of America increased their price objective on Docusign from $58.00 to $64.00 and gave the company an “underperform” rating in a report on Friday, September 4th. BTIG Research raised their target price on shares of Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Finally, Citigroup raised their target price on shares of Docusign from $54.00 to $72.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Docusign has an average rating of “Hold” and an average target price of $67.33.

Get Our Latest Analysis on Docusign

More Docusign News

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Docusign was named a Leader in the 2026 IDC MarketScape for Worldwide Integrated Signing Workflow Software. The recognition supports the company’s competitive position as it expands Intelligent Agreement Management (IAM) and AI-powered workflow products. Docusign Named a Leader in the IDC MarketScape
  • Positive Sentiment: Investors continue to focus on Docusign’s AI initiatives, including IAM integrations and the opening of its Model Context Protocol Server to AI agents. The company also raised full-year revenue guidance and completed a $2.38 billion share-repurchase program covering slightly more than 20% of its shares, potentially supporting earnings per share and shareholder returns. Docusign’s AI Push and Buyback
  • Positive Sentiment: Analysts raised the consensus price target by 17.43% to $71.83, indicating improved expectations for DOCU’s valuation and outlook. DocuSign Consensus Price Target Raised
  • Positive Sentiment: Recent results showed revenue of $875.75 million, net income of $77.72 million and stronger-than-expected earnings, while revenue increased 9.4% year over year. These results, along with buybacks and AI adoption, have reinforced the bullish long-term case. Reasons to Hold Docusign Stock
  • Neutral Sentiment: Director Anna Marrs sold 548 shares for approximately $36,716 under a pre-arranged Rule 10b5-1 plan. Because the sale was planned and represented only 3.89% of her holdings, it is less likely to signal a change in management’s outlook. SEC Insider Trading Filing

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Docusign during the second quarter valued at approximately $927,059,000. Norges Bank acquired a new stake in shares of Docusign during the 4th quarter worth approximately $186,795,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Docusign by 76.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock worth $250,568,000 after purchasing an additional 2,283,996 shares during the last quarter. Capital World Investors lifted its holdings in shares of Docusign by 38.1% in the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock worth $397,801,000 after purchasing an additional 1,603,900 shares during the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in Docusign during the 2nd quarter valued at approximately $56,219,000. 77.64% of the stock is owned by hedge funds and other institutional investors.

Docusign Company Profile

(Get Free Report)

DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.

The company’s products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.

Featured Stories

Insider Buying and Selling by Quarter for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.